383 related articles for article (PubMed ID: 37032724)
1. Obesity and novel management of inflammatory bowel disease.
Kim JH; Oh CM; Yoo JH
World J Gastroenterol; 2023 Mar; 29(12):1779-1794. PubMed ID: 37032724
[TBL] [Abstract][Full Text] [Related]
2. Role of Obesity, Mesenteric Adipose Tissue, and Adipokines in Inflammatory Bowel Diseases.
Bilski J; Mazur-Bialy A; Wojcik D; Surmiak M; Magierowski M; Sliwowski Z; Pajdo R; Kwiecien S; Danielak A; Ptak-Belowska A; Brzozowski T
Biomolecules; 2019 Nov; 9(12):. PubMed ID: 31779136
[TBL] [Abstract][Full Text] [Related]
3. Impact of Obesity on the Course of Management of Inflammatory Bowel Disease-A Review.
Michalak A; Kasztelan-Szczerbińska B; Cichoż-Lach H
Nutrients; 2022 Sep; 14(19):. PubMed ID: 36235636
[TBL] [Abstract][Full Text] [Related]
4. Visceral adiposity and inflammatory bowel disease.
Rowan CR; McManus J; Boland K; O'Toole A
Int J Colorectal Dis; 2021 Nov; 36(11):2305-2319. PubMed ID: 34104989
[TBL] [Abstract][Full Text] [Related]
5. Associations Between Obesity and the Effectiveness of Anti-Tumor Necrosis Factor-α Agents in Inflammatory Bowel Disease Patients: A Literature Review and Meta-analysis.
Dai ZH; Xu XT; Ran ZH
Ann Pharmacother; 2020 Aug; 54(8):729-741. PubMed ID: 31955605
[No Abstract] [Full Text] [Related]
6. Impact of Obesity on Inflammatory Bowel Disease.
Khakoo NS; Ioannou S; Khakoo NS; Vedantam S; Pearlman M
Curr Gastroenterol Rep; 2022 Jan; 24(1):26-36. PubMed ID: 35150406
[TBL] [Abstract][Full Text] [Related]
7. Interaction of obesity and inflammatory bowel disease.
Harper JW; Zisman TL
World J Gastroenterol; 2016 Sep; 22(35):7868-81. PubMed ID: 27672284
[TBL] [Abstract][Full Text] [Related]
8. A systematic review and meta-analysis of prospective studies on obesity and risk of inflammatory bowel disease.
Milajerdi A; Abbasi F; Esmaillzadeh A
Nutr Rev; 2022 Feb; 80(3):479-487. PubMed ID: 34157115
[TBL] [Abstract][Full Text] [Related]
9. Obesity, a challenge in the management of inflammatory bowel diseases.
Rajabnia M; Hajimirzaei SM; Hatamnejad MR; Shahrokh S; Ghavami SB; Farmani M; Salarieh N; Ebrahimi N; Kazemifard N; Farahanie A; Sherkat G; Aghdaei HA
Immunol Res; 2022 Dec; 70(6):742-751. PubMed ID: 36031674
[TBL] [Abstract][Full Text] [Related]
10. Impact of Bariatric Surgery on the Long-term Disease Course of Inflammatory Bowel Disease.
Braga Neto MB; Gregory MH; Ramos GP; Bazerbachi F; Bruining DH; Abu Dayyeh BK; Kushnir VM; Raffals LE; Ciorba MA; Loftus EV; Deepak P
Inflamm Bowel Dis; 2020 Jun; 26(7):1089-1097. PubMed ID: 31613968
[TBL] [Abstract][Full Text] [Related]
11. COVID-19 outcomes in patients with inflammatory bowel diseases in Latin America: Results from SECURE-IBD registry.
Queiroz NSF; Martins CA; Quaresma AB; Hino AAF; Steinwurz F; Ungaro RC; Kotze PG
J Gastroenterol Hepatol; 2021 Nov; 36(11):3033-3040. PubMed ID: 34151470
[TBL] [Abstract][Full Text] [Related]
12. Increased risk of genital warts in inflammatory bowel disease: A Danish registry-based cohort study (1996-2018).
Elmahdi R; Thomsen LT; Iversen AT; Allin KH; Kjaer SK; Jess T
United European Gastroenterol J; 2022 Apr; 10(3):287-295. PubMed ID: 35297191
[TBL] [Abstract][Full Text] [Related]
13. Impact of obesity on disease activity and disease outcome in inflammatory bowel disease: Results from the Swiss inflammatory bowel disease cohort.
Greuter T; Porchet F; Braga-Neto MB; Rossel JB; Biedermann L; Schreiner P; Scharl M; Schoepfer AM; Safroneeva E; Straumann A; Rogler G; Vavricka SR
United European Gastroenterol J; 2020 Dec; 8(10):1196-1207. PubMed ID: 33276710
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of inflammatory bowel disease in the Australian general practice population: A cross-sectional study.
Busingye D; Pollack A; Chidwick K
PLoS One; 2021; 16(5):e0252458. PubMed ID: 34043730
[TBL] [Abstract][Full Text] [Related]
15. Risk of Cervical Cancer in Inflammatory Bowel Disease: A Meta-Analysis of Population-Based Studies.
Mann S; Jess T; Allin K; Elmahdi R
Clin Transl Gastroenterol; 2022 Jul; 13(7):e00513. PubMed ID: 35905421
[TBL] [Abstract][Full Text] [Related]
16. An Update on Herbal Products for the Management of Inflammatory Bowel Disease.
Arya H; Dass R; Chopra B; Kriplani P; Deswal G; Singh Grewal A; Dhingra AK; Kumar S
Antiinflamm Antiallergy Agents Med Chem; 2023; 22(1):1-9. PubMed ID: 37497699
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of inflammatory bowel disease in patients with airways disease.
Raj AA; Birring SS; Green R; Grant A; de Caestecker J; Pavord ID
Respir Med; 2008 May; 102(5):780-5. PubMed ID: 18321696
[TBL] [Abstract][Full Text] [Related]
18. Peripartum Infections Among Women With Inflammatory Bowel Disease.
Narkis B; Hadar E; Barbash-Hazan S; Houri O; Shay V; Ollech JE; Yanai H; Dotan I; Avni-Biron I
Inflamm Bowel Dis; 2023 Jul; 29(7):1098-1104. PubMed ID: 36049022
[TBL] [Abstract][Full Text] [Related]
19. Interventions for the management of abdominal pain in Crohn's disease and inflammatory bowel disease.
Sinopoulou V; Gordon M; Akobeng AK; Gasparetto M; Sammaan M; Vasiliou J; Dovey TM
Cochrane Database Syst Rev; 2021 Nov; 11(11):CD013531. PubMed ID: 34844288
[TBL] [Abstract][Full Text] [Related]
20. Obesity in adult patients with inflammatory bowel disease: Clinical features and impact on disability. A cross-sectional survey from the GETAID.
Bacha RA; Bouhnik Y; Serrero M; Filippi J; Roblin X; Bourrier A; Bouguen G; Franchimont D; Savoye G; Buisson A; Louis E; Nancey S; Abitbol V; Reimund JM; DeWit O; Vuitton L; Mathieu N; Peyrin-Biroulet L; Gilletta C; Allez M; Viennot S; Berre CL; Laharie D; Nachury M; Amiot A;
Dig Liver Dis; 2023 Dec; 55(12):1632-1639. PubMed ID: 37246095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]